View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Carole Braudeau
  • Carole Braudeau

Credit Morning 12/18/2025

Moody’s downgrades SES rating from Baa3/negative to Ba1/stable|ams OSRAM launches a € 300m tender offer on the 2027 convertible bonds|

Carole Braudeau
  • Carole Braudeau

Morning Crédit 18/12/2025

Moody’s dégrade le rating de SES de Baa3/négative à Ba1/stable|ams OSRAM lance une offre d’achat de 300 m EUR sur les obligations convertibles 2027|

Getlink SE: 2 directors

Two Directors at Getlink SE bought 8,584 shares at between 15.154EUR and 15.180EUR. The significance rating of the trade was 62/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last...

Sartorius Stedim Biotech S.A.: 1 director

A director at Sartorius Stedim Biotech S.A. sold 750,000 shares at 211.100EUR and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last ...

 PRESS RELEASE

Philips agrees to acquire SpectraWAVE Inc., advancing next-generation ...

Philips agrees to acquire SpectraWAVE Inc., advancing next-generation coronary intravascular imaging and physiological assessment with AI December 15, 2025 Acquisition of SpectraWAVE’s next-generation technologies including HyperVueTM Imaging System with Enhanced Vascular Imaging for comprehensive, rapid, and AI-supported imaging inside the coronary arteries, and X1TM-FFR, an AI-enabled angio-based FFR technology that delivers rapid, accurate coronary physiology assessment from a single angiogram [1] SpectraWAVE’s technologies have the potential to significantly increase adoption of corona...

Jerôme Bodin
  • Jerôme Bodin

Publicis : Feedback de roadshow en Amérique du Nord, objectif de cours...

Nous avons organisé un roadshow en Amérique du Nord avec Jean-Michel Bonamy, Deputy CFO. Le message reste positif sur la tendance organique pour le T4 et 2026. Nous en ressortons avec une conviction renforcée sur le momentum 2026 et au-delà avec une solide croissance de BPA, et, selon nous, un possible recours accru au rachat d’actions si l'enveloppe de M&A devait ne pas être dépensée en totalité. Nous réitérons notre opinion Surperformance sur le titre avec un objectif de cours porté à 115 € (v...

Jerôme Bodin
  • Jerôme Bodin

Publicis : Feedback from road show in North America, target price rais...

We organised a road show in North America with Jean-Michel Bonamy, Deputy CFO. The message remains positive about the organic trend for Q4 and 2026. We have come away with a stronger belief in the 2026 momentum and beyond, with solid EPS growth and, in our view, potential increased use of share buybacks if the M&A envelope is not spent in full. We reiterate our Outperform rating on the stock with a target price adjusted to € 115 (vs € 110) as a result of a slight increase in our long-term margin...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch